Potential use of botulinum toxin type A for controlling contraction of skin grafts.
Xiao
X
Zhibo
D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D016207:Cytokines / Q000378:metabolism; D005347:Fibroblasts / Q000166:cytology; D006085:Graft Survival; D006801:Humans; D008954:Models, Biological; D019651:Plastic Surgery Procedures / Q000379:methods*; D016038:Skin Transplantation / Q000379:methods*; D013718:Tensile Strength; D053773:Transforming Growth Factor beta1 / Q000378:metabolism
D016207:Cytokines; D053773:Transforming Growth Factor beta1; D019274:Botulinum Toxins, Type A